D&D Pharmatech Inc. (KOSDAQ:347850)
33,900
-3,500 (-9.36%)
Nov 20, 2026, 3:30 PM KST
| Market Cap | 1.55T -60.4% |
| Revenue (ttm) | 2.75B -70.5% |
| Net Income | -21.60B |
| EPS | -824.34 |
| Shares Out | 45.84M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 510,033 |
| Open | 35,750 |
| Previous Close | 37,400 |
| Day's Range | 33,450 - 35,950 |
| 52-Week Range | 33,450 - 116,600 |
| Beta | 1.66 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Mar 19, 2027 |